Applicant, as named in the Orange Book

Cephalon

Next listed expiry: Treanda on 26 Apr 2031. 1 products with live protection, 2 without.

Products with listed protection

Drug	Ingredient	NDA	Earliest generic entry	Basis
Treanda · 2 strengths bendamustine hydrochloride	bendamustine hydrochloride	022249	26 Apr 2031	patent

No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.

Products without listed protection (2)

Drug	Ingredient	NDA	Earliest generic entry	Basis
Gabitril · 4 strengths tiagabine hydrochloride	tiagabine hydrochloride	020646	open now	no listed protection
Trisenox arsenic trioxide	arsenic trioxide	021248	open now	no listed protection